Research programme: bacteriophage therapeutics - Ferring Pharmaceuticals/Institut Pasteur
Latest Information Update: 18 May 2015
At a glance
- Originator Ferring Pharmaceuticals; Institute Pasteur
- Class Bacteriophages
- Mechanism of Action Bacterial DNA modulators; Bacterial RNA modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Inflammatory bowel diseases
Most Recent Events
- 17 Apr 2015 Early research in Inflammatory bowel disease in Switzerland (unspecified route)